Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

5.510 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
News headline image
Earnings Preview For KORU Medical Systems ↗
 
Via Benzinga
News headline image
Repro-Med Systems's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
A Preview Of Repro-Med Systems's Earnings ↗
 
Via Benzinga
News headline image
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
From KORU Medical Systems
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
From KORU Medical Systems
Via Business Wire
News headline image
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026 ↗
B. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗
 
Via Benzinga
News headline image
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 8, 2023 ↗
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.